Helen T Shin

Oct 14, 2024 | dermatologytimes.com | Karan Lal |Helen T Shin

OpinionVideoOctober 14, 2024Author(s): Long-term safety and efficacy of systemic and biologic therapies in children require more comprehensive studies. Understanding the psychosocial impact of psoriasis on pediatric patients and families is crucial for holistic care. Personalized treatment approaches, considering genetic and environmental factors, could optimize therapeutic strategies.

Oct 7, 2024 | dermatologytimes.com | Karan Lal |Helen T Shin

OpinionVideoOctober 7, 2024Author(s):Panelists discuss how the two approved PDE4 inhibitors for pediatric plaque psoriasis differ in their systemic treatments, highlighting key differences in efficacy, safety profiles, and patient considerations for optimal use. Video content above is prompted by the following:Currently there are two approved PDE4 inhibitors in this category.

Oct 7, 2024 | dermatologytimes.com | Karan Lal |Helen T Shin

OpinionVideoOctober 7, 2024Author(s):Panelists discuss how phosphodiesterase-4 (PDE4) inhibitors, with their ability to modulate inflammatory pathways, hold promise as therapeutic targets for immune-mediated diseases like pediatric plaque psoriasis, offering unique benefits by potentially reducing inflammation with a favorable safety profile for pediatric patients.

Sep 30, 2024 | dermatologytimes.com | Karan Lal |Helen T Shin

September 30, 2024By Karan Lal, DO, and Helen T Shin, MD, discuss how early diagnosis of pediatric plaque psoriasis significantly improves management strategies and enhances long-term outcomes by allowing for timely intervention and personalized treatment plans. Video content above is prompted by the following:How does early diagnosis impact the management and long-term outcomes of pediatric plaque psoriasis? (Herbert, 2023)Related Content Related Content

Sep 30, 2024 | dermatologytimes.com | Karan Lal |Helen T Shin

September 30, 2024By Panelists discuss how limited treatment options, safety concerns, adherence issues, and the lack of long-term data pose significant challenges in effectively managing pediatric vs adult plaque psoriasis, highlighting the need for more research and tailored approaches for this patient population. Video content above is prompted by the following:What are the current challenges and unmet needs in the treatment of pediatric plaque psoriasis? Related Content Related Content